4//SEC Filing
Schall Thomas J. 4
Accession 0001628280-24-028072
CIK 0001790340other
Filed
Jun 12, 8:00 PM ET
Accepted
Jun 13, 4:26 PM ET
Size
5.4 KB
Accession
0001628280-24-028072
Insider Transaction Report
Form 4
Immuneering CorpIMRX
Schall Thomas J.
Director
Transactions
- Award
Stock Option
2024-06-12+8,588→ 8,588 totalExercise: $1.54Exp: 2034-06-12→ Class A Common Stock (8,588 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable in equal monthly installments over a one-year period commencing on July 12, 2024, and will be fully vested and exercisable on June 12, 2025, or the date of the 2025 annual meeting of stockholders, whichever comes first.
Documents
Issuer
Immuneering Corp
CIK 0001790340
Entity typeother
Related Parties
1- filerCIK 0001423084
Filing Metadata
- Form type
- 4
- Filed
- Jun 12, 8:00 PM ET
- Accepted
- Jun 13, 4:26 PM ET
- Size
- 5.4 KB